Growth Metrics

Ekso Bionics Holdings (EKSO) Total Non-Current Liabilities (2016 - 2026)

Ekso Bionics Holdings has reported Total Non-Current Liabilities over the past 14 years, most recently at $11.0 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 21.15% to $11.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.0 million, a 21.15% decrease, with the full-year FY2025 number at $11.0 million, down 21.15% from a year prior.
  • Total Non-Current Liabilities reached $11.0 million in Q4 2025 per EKSO's latest filing, down from $11.9 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $16.1 million in Q2 2023, with the low at $8.1 million in Q2 2022.
  • The 5-year median for Total Non-Current Liabilities is $14.1 million (2024), against an average of $13.4 million.
  • Peak YoY movement for Total Non-Current Liabilities: tumbled 36.53% in 2022, then soared 97.44% in 2023.
  • Tracing EKSO's Total Non-Current Liabilities over 5 years: stood at $11.9 million in 2021, then rose by 28.26% to $15.2 million in 2022, then increased by 4.71% to $15.9 million in 2023, then fell by 12.55% to $13.9 million in 2024, then dropped by 21.15% to $11.0 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $11.0 million, $11.9 million, and $12.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.